Clinical Trial Update: Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors [Phase 3]

View source ↗

Summary

This clinical trial update outlines a Phase 3 study in lung cancer evaluating the efficacy and biomarker development for patients treated with immune checkpoint…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Lung Cancer | Phase 3 | Status: RECRUITING